(A) Immunofluorescence (IF) staining showing expression level of Six2, non-phospho (NP) β-catenin and Jag1 in nephron progenitor cell (NPC) cultured in NPEM supplemented with various CHIR dosages. (B…
(A) Overview of experiment design and data available (gray). (B) Bar plots show RT-qPCR measurement of relative expression of the indicated genes, as verification of results in Figure 1C. (C) …
(A, B) Genome browser view of RNA-Seq, ATAC-Seq, as well as Six2, H3K27ac, H3K27me3, and Ser5P ChIP-Seq data near Six2 (A) and Wnt4 (B) in low CHIR (left) and high CHIR (right) conditions. Black …
(A) Hierarchical cluster of R-square values between normalized ATAC-Seq reads within merged peaks from all samples. (B) Histograms of distances from differentially accessible (DA) chromatin regions …
(A) Bar plots showing RNA-Seq measured expression levels of TCF/LEF family factors in NPC cultured in nephron progenitor expansion medium (NPEM) culture supplemented with various concentrations of …
(A) Immunoblots of TCF/LEF family factors in nephron progenitor cell cultured in nephron progenitor expansion medium with the indicated treatment; red arrows indicate target band. (B) Quantification …
(A) Bar plots show RT-qPCR measurement of relative expression of TCF/LEF family factors, as verification for results in Figure 3A. (B) Bar plots show expression of individual transcripts of TCF/LEF …
(A, B) Genome browser view of Wnt4 enhancer locus showing ChIP-Seq signal of TCF/LEF factors in low and high CHIR conditions. (C) Histograms showing binding intensity of TCF/LEF factors and …
(A) Numbers of and overlap between binding sites of the same factors between different conditions. (B) Numbers of and overlap between binding sites of different factors in the same conditions. (C) …
(A) Overlap of direct and indirect Tcf7l1 binding in low CHIR with Lef1 binding in high CHIR (left) and enrichment of ChIP-Seq reads on the two types of binding events. (B) Distribution of ATAC-Seq, …
The ChIP-qPCR target sites were marked as red bins on the top track. The highlighted region is where our data is consistent with Karner’s.
(A) β-Catenin binding sites that overlap with an anchor of chromatin loop in high CHIR99021 (CHIR), the proportion that connects to a transcriptional start site (TSS) (gray in the pie chart) and …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Rabbit polyclonal anti-Six2 | ProteinTech | 11562-1-AP; RRID:AB_2189084 | ChIP (1:200) |
Antibody | Mouse monoclonal IgG1 anti-Six2 | Abnova | H00010736-M01; RRID:AB_436993 | IF (1:1000) |
Antibody | Rabbit polyclonal anti-β-catenin | ThermoFisher | 71–2700; RRID:AB_2533982 | ChIP (1:200) |
Antibody | Rabbit monoclonal anti-non-phopho-β-catenin | Cell Signaling Technology | 8814; RRID:AB_11127203 | ChIP (1:200), IF (1:500) and western blot (1:1000) |
Antibody | Mouse monoclonal anti-Tcf7l1 | Santa Cruz | sc-166411; RRID:AB_2302942 | IF (1:1000), western blot (1:1000) |
Antibody | Rabbit polyclonal anti-Tcf7l1 | Thermo Scientific | PA5-40327; RRID:AB_2577173 | ChIP (1:200) |
Antibody | Rabbit monoclonal anti-Tcf7l2 | Cell Signaling Technology | 2569; RRID:AB_2199816 | ChIP (1:200), IF (1:500), western blot (1:1000) |
Antibody | Rabbit monoclonal anti-Tcf7 | Cell Signaling Technology | 2203; RRID:AB_2199302 | ChIP (1:200), western blot (1:1000) |
Antibody | Rat monoclonal IgG2b anti-Tcf7 | R and D Systems | MAB8224 | IF (1:100) |
Antibody | Rabbit monoclonal anti-Lef1 | Cell Signaling Technology | 2230; RRID:AB_823558 | ChIP (1:200), IF (1:500), western blot (1:1000) |
Antibody | Rabbit monoclonal anti-histone H3 | Abcam | ab1791; RRID:AB_302613 | Western blot (1:1000) |
Antibody | Rabbit monoclonal anti-histone H3K27ac | Abcam | ab4729; RRID:AB_2118291 | ChIP (1:200) |
Antibody | Mouse monoclonal anti-histone H3K27me2me3 | Active Motif | 39536; RRID:AB_2793247 | ChIP (1:200) |
Antibody | Mouse monoclonal anti-Ser5P-RNAPII | Millipore | 05–623; RRID:AB_309852 | ChIP (1:200) |
Antibody | Goat polyclonal anti-Jag1 | R and D Systems | AF599; RRID:AB_2128257 | IF (1:50) |
Antibody | HRP-conjugated goat anti-mouse IgG1 | Thermo Scientific | A10551 | Western blot (1:1000) |
Antibody | HRP-conjugated goat anti-rabbit IgG | Cell Signaling Technology | 7074 | Western blot (1:1000) |
Antibody | Alexa647 mouse anti-rat IgG2b | Abcam | ab172335 | IF (1:500) |
Antibody | Alexa555 donkey anti-rabbit IgG | Abcam | ab150074 | IF (1:500) |
Antibody | Alexa488 goat anti-mouse IgG1 | Thermo Scientific | A10551 | IF (1:500) |
Commercial assay or kit | SuperScript IV VILO Master Mix with ezDNase Enzyme | Thermo Fisher Scientific | 11766050 | |
Commercial assay or kit | Luna Universal qPCR Master Mix | New England Biolab | M3003 | |
Commercial assay or kit | RNeasy micro kit | Qiagen | 74004 | |
Commercial assay or kit | KAPA Stranded mRNA-Seq Kit | Kapa Biosystems | KK8420 | |
Commercial assay or kit | SimpleChIP chromatin IP buffers | Cell Signaling Technology | 14231 | |
Commercial assay or kit | Protein A/G agarose beads | Thermo Fisher Scientific | 20423 | |
Commercial assay or kit | minElute reaction cleanup kit | Qiagen | 28204 | |
Commercial assay or kit | SEA block | Thermo Fisher Scientific | 107452659 | |
Commercial assay or kit | Thruplex DNA library prep kit | Clontech | R400523 | |
Software, algorithm | Partek Flow platform | Partek (https://www.partek.com/partek-flow/) | ||
Software, algorithm | DESeq2 | Love et al., 2014 | RRID:SCR_015687 | |
Software, algorithm | DAVID | Huang et al., 2009 (http://david.abcc.ncifcrf.gov/) | RRID:SCR_001881 | |
Software, algorithm | Homer | Heinz et al., 2010 (http://homer.ucsd.edu/) | RRID:SCR_010881 | |
Software, algorithm | QuEST | Valouev et al., 2008 | ||
Software, algorithm | GREAT | McLean et al., 2010 |
Differentially expressed genes (DEG) between conditions.
Differentially accessible regions (DAR) between conditions.
Tcf7l1 and Lef1 peak coordinates by category as in Figure 4.
Hi-C loops to transcriptional start site (TSS).
Hi-C loops that are anchored on β-catenin binding sites in high CHIR99021 (CHIR) condition.
Expression of Wnt target genes published in Karner et al., 2011).